Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Markets PR Newswire By PR Newswire 19 Oct 2026 20:05 1 min read
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

First-of-its-kind clearance combines two advanced wound care technologies into one path for active healing to help streamline care and improve patient outcomes Clearance pairs innovative synthetic electrospun fiber matrix technology with an industry-leading negative pressure wound therapy...

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Call it yourself

No calls on $SOLV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Solventum →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.